Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-01-19 @ 5:52 PM
Study NCT ID:
NCT00048295
Status:
COMPLETED
Last Update Posted:
2022-08-15
First Post:
2002-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2002-10-29
First Submit QC Date:
None
Study First Post Date:
2002-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-11
Last Update Post Date:
2022-08-15
Last Update Post Date Type:
ACTUAL